-
Global Benlysta Market Forecast To Reach $3.6 Billion By 2029 With 11.2% Annual Growth
28 Jul 2025 12:53 GMT
… in immunology, innovative drug delivery systems, collaborations … on medical goods and services, including hospital care, pharmaceuticals, … increased investment in treatments for chronic autoimmune … 47;report/benlysta-global-market-report
What …
-
Treatment pipeline for cutaneous lupus may ‘offer hope very soon’
18 Jul 2025 16:12 GMT
… phase 3 trial for the drug in CLE is … topical and oral medications. These treatments are often not … stimulator (BLyS) belimumab (Benlysta, GlaxoSmithKline) to anifrolumab … , Nektar, Nuvig Pharmaceuticals, Pfizer, Regeneron, Rome Pharmaceuticals, Sanofi, Takeda …
-
Pledging ‘Radical Transparency,’ FDA Reveals Drug Rejection Letters — With Limits
13 Jul 2025 18:50 GMT
… GSK drug at home. Intravenously infused Benlysta was … vaccine as mNEXSPIKE. In the key clinical trial … FDA approved KalVista Pharmaceuticals’ Ekterly, making the pill the first oral on-demand treatment … drug that the biotech had developed as a treatment for …
-
Key FDA approvals in pediatric health: First half of 2025
05 Jul 2025 13:34 GMT
… vaccination rates remain low.
The FDA approved epinephrine nasal spray (neffy; ARS Pharmaceuticals … 3 trials, the treatment significantly … trial, clesrovimab reduced medically … FDA approved a 200 mg/mL autoinjector formulation of belimumab (Benlysta …
-
FDA News Recap: June 2025
02 Jul 2025 15:05 GMT
… Drug GMRx2 (WIDAPLIK) for Hypertension Treatment
On June 9, 2025, George Medicines announced FDA … phase 3 trials and the VERONICA … 2025, Amneal Pharmaceuticals announced FDA approval of prednisolone … patients.
FDA Approves Belimumab (Benlysta) Autoinjector for …
-
FDA news in pediatrics: June 2025
01 Jul 2025 20:03 GMT
… treatments without medication side effects.
On June 9, 2025, the FDA … phase 3 SMART trials, which demonstrated that … the CLEVER trial, clesrovimab reduced medically attended lower … (KalVista Pharmaceuticals), an investigational oral treatment for hereditary …
-
FDA Approves Benlysta Autoinjector for Pediatric Patients With Active Lupus Nephritis
01 Jul 2025 02:29 GMT
-
FDA Approves Benlysta Autoinjector for Pediatric Patients With Active Lupus Nephritis
30 Jun 2025 22:37 GMT
… Food and Drug Administration has approved an autoinjector of Benlysta (belimumab … adverse reactions seen with Benlysta were serious infections, … . "Having the Benlysta autoinjector provides a much … frequent clinic visits for treatment and add greater …
-
FDA Approves Benlysta Autoinjector for Pediatric Lupus Nephritis
27 Jun 2025 16:55 GMT
… the U.S. Food and Drug Administration (FDA) has approved a 200 … aggressive and severe. Having the Benlysta autoinjector provides a much-needed … receive an effective treatment at home, easing their treatment journey.”
Caregivers of …
-
GSK (GSK) Gains FDA Approval for Benlysta Autoinjector for Lupus Treatment
28 Jun 2025 16:50 GMT
… GSK) Gains FDA Approval for Benlysta Autoinjector for Lupus Treatment A pharmacist … gastrointestinal drugs. Benlysta autoinjector is the first-of-its-kind treatment option … researches, develops, and sells medicines and vaccines for infectious diseases, HIV, …